Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
Slashdot It! Slashdot Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
Submit to Reddit Submit Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes to Reddit
Reading: Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetesTwitter This Reading: Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetesTwitter Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes
Add to Facebook Add Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes to Facebook

Low-dose aspirin does not appear to reduce risk of CV events in patients with diabetes

November 10, 2008

Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type 2 diabetes, according to a new study in JAMA. However, aspirin did significantly reduce the combination of fatal coronary and fatal cerebrovascular events. The article is being released early online Sunday, November 9 to coincide with its scientific presentation at the American Heart Association meeting. The study will appear in the November 12 print issue of JAMA.

"Diabetes mellitus is a powerful risk factor for cardiovascular events," the authors write. "Individuals with diabetes have a two- to four-fold increased risk of developing cardiovascular events than those without diabetes." The authors note that the "American Diabetes Association recommends use of aspirin as a primary prevention strategy in patients with diabetes who are at increased cardiovascular risk," including those who are older than 40 years or who have additional risk factors, such as family history, hypertension or smoking.




In this study conducted by Hisao Ogawa, M.D., Ph.D., from the Graduate School of Medical Sciences, Kumamoto University, Japan and colleagues from the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) Trial Investigators, the researchers examined whether low-dose aspirin would be beneficial for primary prevention of atherosclerotic (atherosclerosis, which involves narrowing or hardening of the arteries because of plaque build-up) events in patients with type 2 diabetes. From Dec. 2002 through April 2008, 2,539 patients with type 2 diabetes and no history of atherosclerotic disease from 163 institutions from throughout Japan were enrolled in the study. Patients were randomly assigned to the low-dose aspirin group receiving 81 or 100 mg per day (n = 1,262) or the nonaspirin (n = 1,277) group. The average age was 65 and 55 percent of the patients were men. The median (midpoint) follow-up period was 4.37 years. The main outcome measures were atherosclerotic events, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, and peripheral arterial disease.

"A total of 154 atherosclerotic events occurred: 68 in the aspirin group and 86 in the nonaspirin group," the researchers write. "In the 1,363 patients aged 65 years or older (719 in the aspirin group and 644 in the nonaspirin group), the incidence of atherosclerotic events was significantly lower in the aspirin group (45 events, 6.3 percent) than in the nonaspirin group (59 events, 9.2 percent)." In the 1,176 patients younger than 65 the difference among events in the two groups was not significant.

Aspirin was well tolerated: in comparing bleeding events, the researchers reported 13 hemorrhagic strokes, with no statistically significant difference between aspirin takers and non-takers (six such strokes in the aspirin group; seven in the non-aspirin group). There was a comparable number of the combined endpoint of serious hemorrhagic events (hemorrhagic strokes and major gastrointestinal bleeds).

"Myocardial infarction [heart attack] and ischemic stroke are leading causes of mortality and morbidity in patients with type 2 diabetes. Given the rapid increase in the number of patients with type 2 diabetes worldwide and especially in Asia, establishing effective means of primary prevention of coronary and cerebrovascular events is an important public health priority," the authors comment.

While this study did not find that low-dose aspirin significantly reduced the risk of atherosclerotic events in primary prevention therapy in patients with type 2 diabetes, the authors suggest more research is needed. "These findings should be interpreted in context with the low incidence of atherosclerotic disease in Japan and the current management practice for cardiovascular risk factors and suggest the need to conduct additional studies of aspirin for primary prevention of cardiovascular disease in diabetic patients."

JAMA and Archives Journals





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Gamma-ray Bursts   Neanderthal   life on Mars   Cigarettes   Bisphenol A   Medulloblastoma   Post-traumatic Stress   Drugs   Cognitive Function   Language   Circadian Clock   Solar System   Insulin Resistance   Dengue   Saturns Rings   Epilepsy   Restless Legs Syndrome   Neutron   Hot Flashes   Tooth Decay   Preterm Birth   Pre-eclampsia   Mussels   Snowmelt   Maize  
Related Atherosclerotic Current Events and Atherosclerotic News Articles Atherosclerotic Current Events and Atherosclerotic News RSS Atherosclerotic Current Events and Atherosclerotic News RSS
Patients with moderate to severe periodontitis need evaluation for heart disease risk
Additional research is called for and patients with moderate to severe periodontitis should receive evaluation and possible treatment to reduce their risk of atherosclerotic cardiovascular disease (CVD).

Following the dietary guidelines may slow heart disease in women
The Dietary Guidelines for Americans (DGA) provide guidance to promote health and reduce risk of chronic diseases.

Nanoparticle created to attack cardiovascular plaque
Scientists and engineers at UC Santa Barbara and the Burnham Institute for Medical Research have developed a nanoparticle that can attack plaque-a major cause of cardiovascular disease.

What separates dangerous blood vessel plaques from benign ones
Researchers say they have evidence to explain what separates your average blood vessel plaque from those that are at high risk for triggering the development of dangerous-even fatal-blood clots.

Promising 3-year data: Saving limbs with drug-eluting stents
Attempts to treat critical limb ischemia in peripheral arterial disease (PAD) patients with below-the-knee angioplasty are still thwarted by restenosis (the re-narrowing of the artery at the site of angioplasty or stenting), the need for repeat treatments and the continued progression of atherosclerotic disease, leading to tissue death (gangrene) and amputation.

Simple test helps predict heart attack risk
The use of common and readily available screening tests-like the ankle brachial index (ABI)-along with traditional risk scoring systems-such as the Framingham Risk Score-has the potential to prevent devastating heart attacks in thousands of individuals who are not originally thought to be at high risk (according to Framingham alone), say researchers at the Society of Interventional Radiology's 34th Annual Scientific Meeting.

Hebrew University scientist develop technique for eliminating reblockage of arteries
An easily implementable technique to avoid reblockage of arteries that have been cleared through angioplasty and stent insertion has been developed by researchers led by Prof. Boris Rubinsky of the Hebrew University of Jerusalem.

Potential atherosclerosis drug exhibits no harmful side-effects in liver
Researchers have developed and tested a synthetic atherosclerosis drug that can reduce the build-up of dangerous blood vessel plaques without producing the side-effect of fatty liver disease (which leads to its own set of problems like diabetes). The encouraging results of this study in mice could lead to a new type of drug to treat or even prevent atherosclerosis.

International study identifies gene variants associated with early heart attack
The largest study ever completed of genetic factors associated with heart attacks has identified nine genetic regions - three not previously described - that appear to increase the risk for early-onset myocardial infarction.

Effects of smoking linked to accelerated aging protein
A University of Iowa study is apparently the first to make a connection between a rare, hereditary premature aging disease and cell damage that comes from smoking. The study results point to possible therapeutic targets for smoking-related diseases.
More Atherosclerotic Current Events and Atherosclerotic News Articles
The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management

The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management
by Renu Virmani (Editor), Jagat Narula (Editor), Martin B. Leon (Editor), James T. Willerson (Editor)

Finally, a convenient, one-volume summary of current knowledge on an area of increasing importance! The Vulnerable Atherosclerotic Plaque presents contributions from the best investigators in the field, skillfully edited for easy reading and lavishly illustrated with high-quality, full-color images.

After a considered and concise introduction, the book concentrates on:

Pathology of vulnerable plaque
Triggers for plaque rupture
Imaging of unstable plaque
Management of vulnerable plaques

Careful editing allows the authors to avoid repetition and provide comprehensive coverage of pathology, detection, and management. This thorough and authoritative reference will change the way interventionists look at the disease.

Assessing and Modifying the Vulnerable Atherosclerotic Plaque

Assessing and Modifying the Vulnerable Atherosclerotic Plaque
by Wiley-Blackwell

Mount Sinai School of Medicine, New York, NY. Contains the factors influencing the natural history of plaques, the correlation of vascular lesions and clinical syndromes. Discusses examples of new methods of imaging that will lead to better modalities of prevention and treatment. DNLM: Arteriosclerosis--diagnosis.

Chinese Herbal Medicine for Atherosclerotic occlusive disease

Chinese Herbal Medicine for Atherosclerotic occlusive disease
by Hsin Kuang Herbal Store

Claudication, which is defined as reproducible ischemic muscle pain, is one of the most common manifestations of peripheral vascular disease caused by atherosclerosis.Claudication occurs during physical activity and is relieved after a short rest. Pain develops because of inadequate blood flow. The objective of this treatment is to improve all sysmptoms, prevent and treat later complications, correct imbalance, adjust the immune system and most importantly to boost energy and strong body for better health and quality of life. The purpose of this treatment is not to replace necessary orthodox medical treatment. A combination of both is recommended.

Assessing and Modifying the Vulnerable Atherosclerotic Plaque (American Heart Association Monograph Series)

Assessing and Modifying the Vulnerable Atherosclerotic Plaque (American Heart Association Monograph Series)
by Valentin Fuster MD PhD (Editor), William Insull Jr. MD (Editor)

Mount Sinai School of Medicine, New York, NY. Contains the factors influencing the natural history of plaques, the correlation of vascular lesions and clinical syndromes. Discusses examples of new methods of imaging that will lead to better modalities of prevention and treatment. DNLM: Arteriosclerosis--diagnosis.

Endovascular Therapy for Atherosclerotic Renal Artery Stenosis: Present and Future

Endovascular Therapy for Atherosclerotic Renal Artery Stenosis: Present and Future
by Michael R. Jaff (Editor)

Atherosclerotic renal artery stenosis is now recognized as a common cause of accelerated hypertension and deterioration in renal function, and has become a widely discussed and debated topic in modern cardiovascular medicine. There are multiple reasons for this, including an aging population, improved imaging methods, novel safe and effective methods of revascularization, and improvement in antiplatelet therapy and access site complications after percutaneous procedures.

This monograph presents state of the art contributions in the areas of diagnosis and surgical, medical, and endovascular intervention from leading experts in the field of atherosclerotic renal artery stenosis. It discusses the incidence and prevalence, natural history, diagnosis, and optimal methods of...

Left or right carotid endarterectomy in patients with atherosclerotic disease: Ipsilateral effects on cognition? [An article from: Brain and Cognition]

Left or right carotid endarterectomy in patients with atherosclerotic disease: Ipsilateral effects on cognition? [An article from: Brain and Cognition]
by N. Brand (Author), E. Bossema (Author), M. Ommen (Author), F. Moll (Author), Ackerstaf (Author)

This digital document is a journal article from Brain and Cognition, published by Elsevier in 2004. The article is delivered in HTML format and is available in your Amazon.com Media Library immediately after purchase. You can view it with any web browser.

Description:
We evaluated hemispheric functions ipsilateral to the side of carotid endarterectomy (CEA) in patients with a severe stenosis in the left or right carotid artery. Assessments took place 1 day before and 3 months after CEA. Only right-handed males were included. Nineteen patients underwent surgery of the left carotid artery and 17 of the right. Valid instruments for hemispheric function were included, such as verbal dichotic listening, finger tapping, and a lateralised test for motor planning. Results showed that,...

High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy

High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy
by CRC

Vulnerable plaques are associated with inflammation, apoptosis, rupture, and thrombosis. A detailed understanding of the cellular and molecular pathogenesis of high-risk plaques, together with the ability to visualize and diagnose the lesions, will lead to effective treatments for acute coronary syndromes. High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy brings together timely, authoritative, and in-depth reviews by renowned international cardiologists and scientists covering the definition, structure, and cellular and molecular mechanisms of high risk plaque development, animal models of vulnerable plaque, plaque imaging, and current and future therapies.

  Physical activity and health: atherosclerotic, metabolic, and hypertensive diseases.: An article from: Research Quarterly for Exercise and Sport
by Claude Bouchard (Author), Jean-Pierre Despres (Author)

This digital document is an article from Research Quarterly for Exercise and Sport, published by American Alliance for Health, Physical Education, Recreation and Dance (AAHPERD) on December 1, 1995. The length of the article is 6791 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

From the supplier: A review of scientific evidence on the negative effects of sedentarism on health is presented. Physical inactivity can lead to a number of diseases that will be more prevalent with age. The presence of a regular physical activity can help prevent atherosclerotic, metabolic and hypertensive diseases....

  Pathobiology of the Human Atherosclerotic Plague
by Seymour Glagov (Editor), etc. (Editor)



High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy

High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy
by Levon Michael Khachigian (Editor)

Vulnerable plaques are associated with inflammation, apoptosis, rupture, and thrombosis. A detailed understanding of the cellular and molecular pathogenesis of high-risk plaques, together with the ability to visualize and diagnose the lesions, will lead to effective treatments for acute coronary syndromes. High-Risk Atherosclerotic Plaques: Mechanisms, Imaging, Models, and Therapy brings together timely, authoritative, and in-depth reviews by renowned international cardiologists and scientists covering the definition, structure, and cellular and molecular mechanisms of high risk plaque development, animal models of vulnerable plaque, plaque imaging, and current and future therapies.

© 2009 BrightSurf.com